| scholarly article | Q13442814 |
| P50 | author | Lynn Zechiedrich | Q88502772 |
| Zachary C Conley | Q96070645 | ||
| Andrew Chou | Q96070647 | ||
| P2093 | author name string | Truston J Bodine | |
| P2860 | cites work | Moving forward with reactive oxygen species involvement in antimicrobial lethality | Q26995546 |
| Crystal structure of the DNA gyrase GyrA N-terminal domain fromMycobacterium tuberculosis | Q27657595 | ||
| International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases | Q28304595 | ||
| Novel Conserved Genotypes Correspond to Antibiotic Resistance Phenotypes of E. coli Clinical Isolates | Q28534076 | ||
| Topoisomerase IV is a target of quinolones in Escherichia coli | Q33724600 | ||
| Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). | Q33789579 | ||
| Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli | Q33979064 | ||
| A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium) | Q33981107 | ||
| Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe | Q58924160 | ||
| “Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy | Q63859738 | ||
| DNA Topoisomerases | Q64390034 | ||
| Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations | Q33982113 | ||
| Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria | Q34010692 | ||
| Mechanism of plasmid-mediated quinolone resistance | Q34025874 | ||
| SOS response promotes horizontal dissemination of antibiotic resistance genes | Q34285480 | ||
| A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality | Q34472139 | ||
| An epidemic, toxin gene-variant strain of Clostridium difficile | Q34472146 | ||
| Quorum sensing and multidrug transporters in Escherichia coli | Q34478849 | ||
| Molecular mechanisms of antibacterial multidrug resistance | Q34611916 | ||
| Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study | Q34680622 | ||
| Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection | Q34814831 | ||
| Amdinocillin (Mecillinam) resistance mutations in clinical isolates and laboratory-selected mutants of Escherichia coli | Q35076962 | ||
| Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. | Q35123629 | ||
| Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore. | Q35685143 | ||
| Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli | Q35879095 | ||
| The microbiome of uncontacted Amerindians | Q35897279 | ||
| Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality | Q36049005 | ||
| New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate | Q36094929 | ||
| Contributions of the combined effects of topoisomerase mutations toward fluoroquinolone resistance in Escherichia coli | Q36295431 | ||
| Escherichia coli Mutants Thermosensitive for Deoxyribonucleic Acid Gyrase Subunit A: Effects on Deoxyribonucleic Acid Replication, Transcription, and Bacteriophage Growth | Q36311967 | ||
| Emergence and global spread of epidemic healthcare-associated Clostridium difficile | Q36708973 | ||
| Bullied no more: when and how DNA shoves proteins around | Q36900710 | ||
| Outer membrane permeability and antibiotic resistance | Q37227443 | ||
| Type II topoisomerases--inhibitors, repair mechanisms and mutations | Q37599175 | ||
| Mechanism of quinolone action and resistance | Q37701591 | ||
| Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. | Q38049220 | ||
| Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success | Q38212925 | ||
| Antibiotic resistance in Escherichia coli in husbandry animals: the African perspective. | Q38870568 | ||
| Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance | Q38906198 | ||
| A decade of discovery: CRISPR functions and applications | Q39350951 | ||
| Quinolone-resistant Haemophilus influenzae: determination of mutant selection window for ciprofloxacin, garenoxacin, levofloxacin, and moxifloxacin | Q39698735 | ||
| Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938. | Q40628012 | ||
| Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolates | Q41975822 | ||
| Expression of multidrug efflux pump genes acrAB-tolC, mdfA, and norE in Escherichia coli clinical isolates as a function of fluoroquinolone and multidrug resistance | Q42111161 | ||
| Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates | Q42234726 | ||
| In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014. | Q45223510 | ||
| Molecular characterization of antibiotic resistance in cultivable multidrug-resistant bacteria from livestock manure | Q46353435 | ||
| Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase | Q46862305 | ||
| Fate of antibiotic resistance genes and their associations with bacterial community in livestock breeding wastewater and its receiving river water | Q47857926 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | e1006805 | |
| P577 | publication date | 2018-03-01 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Wicked: The untold story of ciprofloxacin. | |
| P478 | volume | 14 |
| Q89982262 | Antimicrobial activity of the quinoline derivative HT61 against Staphylococcus aureus biofilms |
| Q58795536 | Idiosyncratic Drug-Induced Liver Injury Due to Ciprofloxacin: A Report of Two Cases and Review of the Literature |
| Q90114640 | Microbial Metabolism Modulates Antibiotic Susceptibility within the Murine Gut Microbiome |
| Q58746958 | Molecular typing and profiling of topoisomerase mutations causing resistance to ciprofloxacin and levofloxacin in species |
| Q61796926 | Sugar and iron: Toward understanding the antibacterial effect of ciclopirox in Escherichia coli |
Search more.